Search

everythinglearnresearchcommunity

for

Search:↓

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

Daclizumab may cause psoriasis-like skin problems in multiple sclerosis patients.

Infliximab can cause SAPHO syndrome, which may improve with Spesolimab and methotrexate.

Imiquimod cream can cause hair loss.

Substance from human umbilical cord blood cells promotes hair growth.

The FDA approved a new Pfizer drug for hair loss in teens.

Isolated limb perfusion is a safe and effective treatment for limb melanoma.

MCPIP1 in myeloid cells is important for skin cancer development and healthy hair growth.

New cytokine-targeted therapies show promise for treating alopecia areata.

The MIRA technique improves cellulite treatment results and patient satisfaction.

Apremilast showed mixed results for treating severe alopecia areata.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Exosomes from Pinctada martensii mucus can safely reduce melanin production, offering a new treatment for skin pigment issues.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Calcipotriol plus betamethasone with microneedling works better than tacrolimus for treating vitiligo.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Some elderly men had healing problems after using imiquimod and diclofenac for skin conditions on their scalps.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

CGF therapy may help hair regrowth and improve scars in DLE patients.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

CGF therapy may effectively treat psoriasis by reducing inflammation.

Cold Atmospheric Plasma shows promise in treating aggressive breast cancer by targeting cancer cells while sparing normal tissue.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Ritlecitinib can help about 14,000 people with severe hair loss.